Related Experiment Videos
Acute versus chronic clonidine treatment effects on conflict behavior in the rat
D.J. Fontana1, D.M. Schefke, R.L. Commissaris
1Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions.
Abstract:
The present study examined the effects of acute and chronic treatment with the alpha-2-adrenoceptor agonist clonidine on behavior in the Conditioned Suppression of Drinking (CSD) conflict paradigm, an animal model for the study of anti-anxiety treatments. In daily 10-min sessions, water-deprived rats were trained to drink from a tube which was occasionally electrified (0.25mA). Electrification was signalled by a tone. Within 3-4 weeks of 4 day/week CSD sessions, control (i.e. non-drug) CSD behavior had stabilized (approximately 40 shock/session and 11ml water/session). Acute treatment with clonidine across a range of doses (1.25-40µg/kg; 10-min pretreatment) did not exert an anti-conflict effect, with doses greater than 5µg/kg significantly depressing unpunished responding (i.e. water intake). Similarly, administration of a single dose of clonidine (40µg/kg) across a range of pretreatment times (10 to 120min) failed to increase punished responding. In contrast, chronic post-test treatment with clonidine (40µg/kg, twice daily for 18 weeks) resulted in a dramatic and time-dependent increase in punished responding, with a latency to onset of approximately 3-4 weeks. The response to an acute challenge with chlordiazepoxide (10mg/kg) or the benzodiazepine antagonist Ro 15-1788 (4.0mg/kg) did not differ in chronic clonidine-versus saline-treated subjects, indicating that benzodiazepine receptor sensitivity had not been affected by this chronic clonidine treatment. An acute challenge with a low dose of clonidine (10µg/kg) decreased punished and unpunished responding in chronic clonidine- or saline-treated subjects. Finally, an acute challenge with the alpha-2-antagonist yohimbine (1.25mg/kg) failed to block the increase in punished responding associated with chronic clonidine treatment, indicating that the anti-conflict effect of this chronic post-test clonidine treatment was not the result of alpha-2-adrenoceptor activation at the time of CSD testing (i.e. not due to drug accumulation). Discontinuation of chronic clonidine treatment resulted in a decline to near saline-treated levels of punished responding over the course of 3 weeks of conflict testing. The relationship of these findings to the anti-anxiety effects of clonidine in humans are discussed.